NBS > Established Leader in Cell Therapy Services

150 years of combined management expertise in manufacturing, regulatory and commercialization for therapeutics development

$8-10 million in annual historic revenues

Manufactured 30,000+ cell therapy product procedures and delivered 6,000+ cell therapies to patients worldwide for more than 100 clients

50,000 square feet of cGMP manufacturing capability located in North America (East Coast and West Coast)

Large scale manufacturing for clients allows lower costs for internal cell therapy development